Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
John G. McHutchison(Gilead Sciences (United States)), Nezam H. Afdhal(Beth Israel Deaconess Medical Center), Marc Bourlière(Universität Hamburg), Stuart C. Gordon(United States Department of Veterans Affairs), Samuel H. Sigal(New York University), Geoffrey Dusheiko(University of the Witwatersrand), M. Rodríguez‐Torres(Puerto Rico Community Foundation), J.M. Jenkins(Unknown), Dickens Theodore, Thomas Berg(Leipzig University of Applied Sciences), Nicole Blackman(GlaxoSmithKline (United States)), Fiona Campbell(University of Birmingham), Mitchell L. Shiffman(Bon Secours Health System)
Cited by 451
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k